Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Not Applicable
Recruiting
- Conditions
- PharmacyOncologyCancerDrug Prescriptions
- Interventions
- Other: redispensing oral anticancer drugs
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 2500
- Registration Number
- NCT06566560
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study
Early Phase 1
Recruiting
- Conditions
- Scabies
- Interventions
- Diagnostic Test: Skin sampling
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 144
- Registration Number
- NCT06546579
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Real-life Clinical Experience With Ialuadapter Study
Completed
- Conditions
- Recurrent Urinary Tract InfectionInterstitial Cystitis, ChronicOveractive Bladder Syndrome
- Interventions
- Device: Ialuadapter
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT06540248
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
TreatmENT of AnastomotiC LeakagE After COLON Cancer Resection
Not yet recruiting
- Conditions
- Anastomotic LeakageColon CancerResectionTreatment
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT06528054
South East (Zuid Oost) Netherlands Heart Registry
Recruiting
- Conditions
- Coronary Artery DiseaseAcute Coronary SyndromeChronic Coronary Syndrome
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 99999
- Registration Number
- NCT06512493
- Locations
- 🇳🇱
MaastrichtUMC+, Maastricht, Limburg, Netherlands
🇳🇱VieCuri, Venlo, Limburg, Netherlands
🇳🇱Radboud University Medical Centre, Nijmegen, Netherlands
Methylphenidate in KBG Syndrome: N-of-1 Series
Phase 4
Recruiting
- Conditions
- Kbg SyndromeADHD - Combined Type
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT06465641
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
Clinical Trial to Compare Two Surgical Approaches to the Cochlea
Not Applicable
Recruiting
- Conditions
- Cochlear ImplantsHearing Loss, Sensorineural
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT06453343
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands
Hereditary Pheochromocytoma Assessment of Tumour Immunologies
Recruiting
- Conditions
- ParagangliomaPheochromocytoma
- Interventions
- Procedure: Venepuncture
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06444607
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm
Phase 2
- Conditions
- Coronary Spasm
- Interventions
- Drug: Endothelin Receptor AntagonistOther: Placebo control
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT06432452
- Locations
- 🇳🇱
Catharina Ziekenhuis, Eindhoven, Noord-Brabant, Netherlands
🇳🇱Maasstad Hospital, Rotterdam, Zuid-Holland, Netherlands
🇳🇱RadboudUMC, Nijmegen, Netherlands
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
Not Applicable
Recruiting
- Conditions
- Diabetes Mellitus, Type 1Inflammation
- Interventions
- Drug: hyperinsulinaemic hypoglycaemic clamp
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT06422494
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath